Position in RNTX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$3,101,670
+$524,583 QoQ
Shares Held
2,982,375
+50.4% QoQ
Ownership
3.46%
of shares outstanding
% of Portfolio
7.44%
of 13F equity value
Holder Rank
#5
of 59 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in RNTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026BIOS Capital Management, LP holds $41,671,189 across 6 Biotechnology names. RNTX ranks #4 (7.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ACTU |
Actuate Therapeutics, Inc.
|
10,049,996 | $15,376,493 | |
| 2 | IRD |
Opus Genetics, Inc.
|
3,683,429 | $15,138,893 | |
| 3 | CGTX |
Cognition Therapeutics Inc
|
6,000,000 | $6,899,999 | |
| 4 | RNTX |
Rein Therapeutics, Inc.
This page
|
2,982,375 | $3,101,670 | |
| 5 | LTRN |
Lantern Pharma Inc.
|
249,397 | $1,039,985 | |
| 6 | INAB |
In8bio, Inc.
|
80,957 | $114,149 |
All Filings in RNTX
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,101,670 | 2,982,375 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $2,577,087 | 1,982,375 | Shares | Other | 2026-05-13 | |
| 2025-12-31 | $1,961,271 | 1,690,751 | Shares | Other | 2026-02-13 | |
| 2025-09-30 | $1,935,909 | 1,690,751 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $2,367,051 | 1,690,751 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $2,992,629 | 1,690,751 | Shares | Defined | 2025-05-14 | |
| No filing history on record for this holder in this stock. | ||||||